Paige AI Solution for Prostate Cancer Biomarker Detection Receives CE-IVD and UKCA Marks
First European regulatory clearance for Paige’s digital biomarker capabilities NEW YORK--(BUSINESS WIRE)--Paige, a global leader in clinical AI applications in pathology, today announced it received CE-IVD and UKCA marks for the Paige Prostate Biomark...